CDK12 and Fanconi anemia: Genomic profiling should be performed by NGS panel that covers the potentially actionable targets in PC such as DNA damage repair (HRR, MMR and Fanconi anemia genes, and CDK12), phosphatidylinositol-3-kinase (PI3K), and RAS/RAF/MEK pathways.